Minimizing the Burden of Chronic Kidney Disease

  • March 12, 2021
  • 2:00 PM – 3:00 PM ET
  • Online

Chronic Kidney Disease (CKD) is one of the costliest conditions for health insurance providers and yet continues to result in poor patient outcomes. Simple diagnostic tests and tools that could reduce this burden are underutilized, limiting the potential for improved outcomes, quality improvement, and cost savings.

This webinar will provide information on the magnitude of the problem and will provide an evidence-based approach to risk stratification and segmentation. A case study of a comprehensive CKD intervention by a health insurance provider will be presented.

Attendees will learn about:

  • The impact of CKD on clinical, economic, and quality measures
  • Evidence-based approaches to risk stratification and segmentation
  • Patient types that are most likely to benefit from more comprehensive testing, monitoring and interventions
  • Learnings from a CKD population health intervention that are transferrable to the management of members at highest risk of progression and cost escalation


Patrick James, MD
Chief Clinical Officer, Health Plans and Policy
Quest Diagnostics, Inc.

L. Patrick James, MD, is the Chief Clinical Officer, Health Plans and Policy, at Quest Diagnostics. Prior to assuming this role, he served in other senior leadership roles within Quest. Before joining Quest Diagnostics, Dr. James served as Executive Vice President for Pathology and Laboratory Services at LabOne. He spent nine years with Health Midwest, a 14-hospital integrated delivery system in Kansas City, as Medical Director of Hospital Integration. Dr. James’ experience spans Research Medical Center, St. Joseph Hospital in Denver, Colorado, and National Naval Medical Center in Bethesda, Maryland.

Dr. James earned his Medical Degree with honors from St. Louis University in Missouri.

Joseph Vassalotti, MD
Chief Medical Officer
National Kidney Foundation

Dr. Joseph Vassalotti is the Chief Medical Officer of the National Kidney Foundation (NKF) and Clinical Professor of Medicine in the Division of Nephrology, at Icahn School of Medicine at Mount Sinai –New York.

At NKF, his major focus is implementation of evidence-based clinical practice guidelines in chronic kidney disease (CKD), including the NKF’s Kidney Disease Outcomes Quality Initiative (KDOQI), particularly through guidance of the NKF’s primary care initiative, called CKD intercept.

He received his Medical Degree with Distinction in Research from the State University of New York –Stony Brook School of Medicine, and completed an Internal Medicine Residency and Nephrology Fellowship at the Johns Hopkins Hospital.

Mouris Saghir, PhD
Vice President and General Manager
Quest Diagnostics Cardiovascular, Metabolic & Endocrinology Clinical Franchise and Cleveland HeartLab, Quest Diagnostics Cardiometabolic National Center of Excellence

Dr. Mouris Saghir is Vice President and General Manager of the Quest Diagnostics Cardiovascular, Metabolic & Endocrinology Clinical Franchise including Cleveland HeartLab, Quest Diagnostics Cardiometabolic National Center of Excellence. In his current role, Mouris is responsible for cardiovascular diagnostic innovation that can help patients identify their cardiovascular risks and help prevent heart disease, the leading cause of death in the United States.

In his previous roles at Quest Diagnostics, Mouris was the Executive Director, Strategy and Marketing for Professional Lab Services (PLS) focusing on the business-to-business aspect of partnerships with executives of hospitals and health systems. He joined Quest in 2011, serving as Executive Director, Physician Marketing. Mouris earned his PhD in Diagnostic Medicine from Northeastern University, a master’s degree in management from the Sloan School of Management at the Massachusetts Institute of Technology, and a bachelor’s degree in Medical Technology from Ashland University in Ohio.